- About
- Hard Capsules
-
Dosage Form Solutions
- What we do
- Drug Design and Technologies
- Drug Development and Scale-Up
- Manufacturing of Finished Dosage Forms
Dosage Form Solutions
Innovative drug-delivery technologies, specialized manufacturing, and a collaborative approach to address clients’ most pressing product development challenges.
- Knowledge Center
- News & Events
Archived Webinars
Throughout the year, Capsugel hosts and participates in numerous webinars and virtual conferences. Each of these activities gives us an opportunity to showcase our latest products and services, build relationships with customers and partners, and share and gain invaluable insights.
| Webinar |
|---|
Next Generation HPMC Capsules: Bioequivalence and Functional PerformanceFebruary 17, 2016 4 PM CET (10 AM ET) Market Segment: Pharmaceutical Two-piece hard shell capsules made from hydroxypropyl methylcellulose (HPMC) are emerging as an alternative to conventional gelatin capsules for oral drug delivery when there is a physical incompatibility with gelatin. A new HPMC-polymer capsule without secondary gelling agents developed through a thermo-gelation process (Vcaps® Plus) has shown dissolution profiles similar to hard gelatin capsules, including pH and ionic independence. Although HPMC capsules are used in marketed drugs, there are few comparisons of the in vivo performance between gelatin and HPMC in literature. In this webinar, experts will present the in vitro dissolution and an in vivo bioequivalence study comparing the performance of the identical formulation of three different drugs in Vcaps Plus capsules to Hard Gelatin Capsules (HGC). In addition, the circumstances under which the same API and formulation contained in HGC and Vcaps Plus can be expected to provide equivalent performance will be discussed. Presented by:
Next Generation HPMC Capsules: Bioequivalence and Functional PerformanceFebruary 17, 2016 4 PM CET (10 AM ET) Market Segment: Pharmaceutical Click here for access |
Next Generation HPMC Capsules: Bioequivalence and Functional PerformanceJanuary 19, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Two-piece hard shell capsules made from hydroxypropyl methylcellulose (HPMC) are emerging as an alternative to conventional gelatin capsules for oral drug delivery when there is a physical incompatibility with gelatin. A new HPMC-polymer capsule without secondary gelling agents developed through a thermo-gelation process (Vcaps® Plus) has shown dissolution profiles similar to hard gelatin capsules, including pH and ionic independence. Although HPMC capsules are used in marketed drugs, there are few comparisons of the in vivo performance between gelatin and HPMC in literature. In this webinar, experts will present the in vitro dissolution and an in vivo bioequivalence study comparing the performance of the identical formulation of three different drugs in Vcaps Plus capsules to Hard Gelatin Capsules (HGC). In addition, the circumstances under which the same API and formulation contained in HGC and Vcaps Plus can be expected to provide equivalent performance will be discussed. Presented by:
Next Generation HPMC Capsules: Bioequivalence and Functional PerformanceJanuary 19, 2016 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Click here for access |
Performance of gelatin capsules and the next generation of HPMC capsules - Vcaps® PlusDecember 10, 2015 1 PM ET (7 PM CET - 10 AM PT) Market Segment: Pharmaceutical Though HPMC capsules are used in marketed drugs, there are few comparisons of the in vivo performance between gelatin and HPMC available in literature. In this webinar, we present the results of in vitro dissolution and an in vivo bioequivalence study comparing the performance of the identical formulation of three different drugs in Vcaps® Plus capsules to HGC. In addition, the circumstances under which the same API and formulation contained in HG and Vcaps® Plus can be expected to provide equivalent performance will be discussed. In this webinar, you will learn:
Presented by:
Performance of gelatin capsules and the next generation of HPMC capsules - Vcaps® PlusDecember 10, 2015 1 PM ET (7 PM CET - 10 AM PT) Market Segment: Pharmaceutical Click here for access |
The Top 4 Most Expensive Encapsulation Mistakes and How to Avoid ThemDecember 03, 2015 1 PM ET (7 PM CET) Market Segment: Pharmaceutical Encapsulation manufacturing has grown as companies seek faster ways to develop and complete products for commercialization. This webinar will examine four key areas manufacturing and R&D must address to ensure they don’t fall victim to encapsulation mistakes. What you'll learn:
These simple basics are often simply overlooked with significant and costly results. Black-belt quality and engineering specialists will provide the pathway forward to ensure those mistakes can be avoided. Presented by:
The Top 4 Most Expensive Encapsulation Mistakes and How to Avoid ThemDecember 03, 2015 1 PM ET (7 PM CET) Market Segment: Pharmaceutical Click here for access |
Pre & Probiotics Online EventNovember 17, 2015 10:45 AM CET Market Segment: Dietary Supplement In this webinar at the Pre & Probiotics Online Event, Nicolas Madit, Business Development Manager EMEA, will review Capsugel's portfolio of innovative solutions to support the growing probiotic market. He will address existing concerns about lengthening shelf life with low moisture capsules, increasing probiotic release in the intestine with DRcaps™ and propose alternatives for delivering probiotic to pediatric and / or patients with swallowing difficulties. Pre & Probiotics Online EventNovember 17, 2015 10:45 AM CET Market Segment: Dietary Supplement Click here for access |
<< 5 of 14 >>